Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
No independent correlations were found between echocardiographic parameters and haemoglobin, PAPP-A, FGF23 or vitamin D levels.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease: a prospective observational study
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease: a prospective observational study
Observational study · BMC Nephrology · 2013
Original publication title
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease: a prospective observational study
Copyright © 2013 Peiskerová et al.; licensee BioMed Central Ltd.
Original publication · Publisher record · CC BY 2.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the development of LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markers to echocardiographic parameters in CKD population.
Source: BackgroundAbstract: What methods does the paper describe?
We prospectively examined selected laboratory (PlGF, fibroblast growth factor-23: FGF23, vitamin D, parathyroid hormone, extracellular newly identified RAGE-binding protein: EN-RAGE, B-type natriuretic peptide: BNP) and echocardiographic parameters in 62 patients with CKD 2 to 4. Mean follow-up was 36 ±10 months. Laboratory and echocardiographic data were collected 2 to 3 times, at the shortest interval of 12 months apart. Multivariate regression analysis was used to detect independent correlations of variables.
Source: MethodsAbstract: Results
Increased left ventricular mass index (LVMI, g/m2.7) was found in 29% patients with CKD 2 to 4, left ventricular (LV) diastolic dysfunction was detected in 74.1% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 30.6% patients). After 36 ± 10 months increased LVMI was found in 37.1% patients with CKD 2 to 4, LV diastolic dysfunction was detected in 75.8% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 32.3% patients). Following independent correlations were found: LVMI was related to PlGF, cholesterol, BNP, systolic blood pressure and serum creatinine.
EN-RAGE correlated positively with left atrial diameter and inversely with E/A ratio. During the follow-up we found a significant increase in LVMI and left atrial diameter, whereas a significant decrease in LVEF was noted.
Source: ResultsAbstract: Conclusion
According to our data, PlGF is independently related to increased LV mass in CKD, whereas EN-RAGE is more likely related to diastolic dysfunction in this population.
Source: ConclusionAuthors’ abstract
Background
Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the development of LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markers to echocardiographic parameters in CKD population.
Methods
We prospectively examined selected laboratory (PlGF, fibroblast growth factor-23: FGF23, vitamin D, parathyroid hormone, extracellular newly identified RAGE-binding protein: EN-RAGE, B-type natriuretic peptide: BNP) and echocardiographic parameters in 62 patients with CKD 2 to 4. Mean follow-up was 36 ±10 months. Laboratory and echocardiographic data were collected 2 to 3 times, at the shortest interval of 12 months apart. Multivariate regression analysis was used to detect independent correlations of variables.
Results
Increased left ventricular mass index (LVMI, g/m2.7) was found in 29% patients with CKD 2 to 4, left ventricular (LV) diastolic dysfunction was detected in 74.1% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 30.6% patients). After 36 ± 10 months increased LVMI was found in 37.1% patients with CKD 2 to 4, LV diastolic dysfunction was detected in 75.8% patients (impaired LV relaxation in 43.5% patients and pseudonormal pattern in 32.3% patients). Following independent correlations were found: LVMI was related to PlGF, cholesterol, BNP, systolic blood pressure and serum creatinine.
EN-RAGE correlated positively with left atrial diameter and inversely with E/A ratio. During the follow-up we found a significant increase in LVMI and left atrial diameter, whereas a significant decrease in LVEF was noted.
Conclusion
According to our data, PlGF is independently related to increased LV mass in CKD, whereas EN-RAGE is more likely related to diastolic dysfunction in this population.
Publication and source details
Original title: Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease: a prospective observational study
Martina Peiskerová; Marta Kalousová; Vilem Danzig; Blanka Míková; Magdalena Hodková; Eduard Němeček; Amjad Bani-Hani; David Ambrož; Hana Benáková; Ales Linhart; Tomas Zima; Vladimir Tesař
BMC Nephrology · 2013
Copyright © 2013 Peiskerová et al.; licensee BioMed Central Ltd.2013Peiskerová et al.; licensee BioMed Central Ltd.https://creativecommons.org/licenses/by/2.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T12:45:05.039748+00:00
DOI: 10.1186/1471-2369-14-142 · PMC3750451